company
About Us
Management Team
Board of Directors
Advisory Board
pipeline
Overview
Tissue Fibrosis
Endometriosis
Oncology
NEWS
Contact
News & Insights
.
Press Release
Temple Therapeutics Reveals Breakthrough Findings on Ovarian Cancer at AACR 2023
LMTK3 as prognostic marker for ovarian cancer and TTX335o, award-winning drug candidate with tumor-killing activity, presented as game-changing treatment for women
